Together Pharma Statistics

Total Valuation

Together Pharma has a market cap or net worth of ILS 70.08 million. The enterprise value is 127.78 million.

Market Cap	70.08M
Enterprise Value	127.78M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Together Pharma has 13.74 million shares outstanding. The number of shares has increased by 14.48% in one year.

Current Share Class	n/a
Shares Outstanding	13.74M
Shares Change (YoY)	+14.48%
Shares Change (QoQ)	+44.60%
Owned by Insiders (%)	69.15%
Owned by Institutions (%)	0.07%
Float	4.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
PB Ratio	1.38
P/TBV Ratio	n/a
P/FCF Ratio	6.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.47, with an EV/FCF ratio of 11.81.

EV / Earnings	-49.95
EV / Sales	1.33
EV / EBITDA	4.47
EV / EBIT	5.41
EV / FCF	11.81

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.24.

Current Ratio	1.25
Quick Ratio	0.34
Debt / Equity	1.24
Debt / EBITDA	2.05
Debt / FCF	5.43
Interest Coverage	1.31

Financial Efficiency

Return on equity (ROE) is 0.23% and return on invested capital (ROIC) is 17.56%.

Return on Equity (ROE)	0.23%
Return on Assets (ROA)	10.29%
Return on Capital (ROIC)	17.56%
Revenue Per Employee	661,297
Profits Per Employee	-17,641
Employee Count	145
Asset Turnover	0.67
Inventory Turnover	1.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.35% in the last 52 weeks. The beta is 0.43, so Together Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+37.35%
50-Day Moving Average	425.55
200-Day Moving Average	477.15
Relative Strength Index (RSI)	60.42
Average Volume (20 Days)	89,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Together Pharma had revenue of ILS 95.89 million and -2.56 million in losses. Loss per share was -0.26.

Revenue	95.89M
Gross Profit	36.68M
Operating Income	23.68M
Pretax Income	6.77M
Net Income	-2.56M
EBITDA	27.61M
EBIT	23.68M
Loss Per Share	-0.26

Full Income Statement

Balance Sheet

The company has 7.58 million in cash and 58.75 million in debt, giving a net cash position of -51.17 million or -3.72 per share.

Cash & Cash Equivalents	7.58M
Total Debt	58.75M
Net Cash	-51.17M
Net Cash Per Share	-3.72
Equity (Book Value)	47.50M
Book Value Per Share	3.70
Working Capital	17.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.66 million and capital expenditures -1.83 million, giving a free cash flow of 10.82 million.

Operating Cash Flow	12.66M
Capital Expenditures	-1.83M
Free Cash Flow	10.82M
FCF Per Share	0.79

Full Cash Flow Statement

Margins

Gross margin is 38.25%, with operating and profit margins of 24.69% and -2.67%.

Gross Margin	38.25%
Operating Margin	24.69%
Pretax Margin	7.06%
Profit Margin	-2.67%
EBITDA Margin	28.79%
EBIT Margin	24.69%
FCF Margin	11.29%

Dividends & Yields

Together Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.48%
Shareholder Yield	-14.48%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on August 13, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 13, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

Together Pharma has an Altman Z-Score of -0.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.36
Piotroski F-Score	n/a